Pfizer-BioNTech Vaccine Deliveries to Start Before Christmas

Pfizer Inc and BioNTech are likely to secure emergency US and European authorization for their COVID-19 vaccine next month, the companies commented Wednesday, following final trial results showing a 95% success rate and no serious side effects.

The US Food and Drug Administration (FDA) could grant emergency-use by the middle of December, while conditional approval in the European Union could, in turn, be secured in the second half of December.

"If all goes well I could imagine that we gain approval in the second half of December and start deliveries before Christmas, but really only if all goes positively», BioNTech Chief Executive - Ugur Sahin commented.

Sahin further added that US emergency use authorization (EUA) would be applied for on Friday. An FDA advisory committee plans to meet from the 8-10th of December to discuss the vaccine, a competent source said.

*The products advertised are only available to clients under Fondex Limited Seychelles (SDL No: SD037).